These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Accelerated atherosclerosis in beta-thalassemia. Hurtado J; Sellak H; Joseph G; Lewis CV; Naudin CR; Garcia S; Wodicka JR; Archer DR; Taylor WR Am J Physiol Heart Circ Physiol; 2023 Nov; 325(5):H1133-H1143. PubMed ID: 37682237 [TBL] [Abstract][Full Text] [Related]
4. Free heme and hemopexin in acute kidney injury after cardiopulmonary bypass and transient renal ischemia. Greite R; Schott S; Wang L; Gohlke L; Kreimann K; Derlin K; Gutberlet M; Schmidbauer M; Leffler A; Tudorache I; Salman J; Ius F; Natanov R; Fegbeutel C; Haverich A; Lichtinghagen R; Hüsing AM; von Vietinghoff S; Schmitt R; Shushakova N; Rong S; Haller H; Schmidt-Ott KM; Gram M; Vijayan V; Scheffner I; Gwinner W; Immenschuh S Clin Transl Sci; 2023 Dec; 16(12):2729-2743. PubMed ID: 37899696 [TBL] [Abstract][Full Text] [Related]
5. Labile Heme and Heme Oxygenase-1 Maintain Tumor-Permissive Niche for Endometriosis-Associated Ovarian Cancer. Hecht JL; Janikova M; Choudhury R; Liu F; Canesin G; Janovicova L; Csizmadia E; Jorgensen EM; Esselen KM; Celec P; Swanson KD; Wegiel B Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565370 [TBL] [Abstract][Full Text] [Related]
6. Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Vinchi F; Gastaldi S; Silengo L; Altruda F; Tolosano E Am J Pathol; 2008 Jul; 173(1):289-99. PubMed ID: 18556779 [TBL] [Abstract][Full Text] [Related]
7. Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice. Tolosano E; Hirsch E; Patrucco E; Camaschella C; Navone R; Silengo L; Altruda F Blood; 1999 Dec; 94(11):3906-14. PubMed ID: 10572107 [TBL] [Abstract][Full Text] [Related]
8. HO-1 and Heme: G-Quadruplex Interaction Choreograph DNA Damage Responses and Cancer Growth. Canesin G; Muralidharan AM; Swanson KD; Wegiel B Cells; 2021 Jul; 10(7):. PubMed ID: 34359970 [TBL] [Abstract][Full Text] [Related]
9. Heme Oxygenase Activity and Heme Binding in a Neonatal Mouse Model. Kourula S; Ang J; Zhao H; Kalish F; Vandenabeele P; Sylvester KG; Wong RJ; Stevenson DK Neonatology; 2017; 112(4):376-383. PubMed ID: 28926834 [TBL] [Abstract][Full Text] [Related]
10. Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases. Vinchi F; De Franceschi L; Ghigo A; Townes T; Cimino J; Silengo L; Hirsch E; Altruda F; Tolosano E Circulation; 2013 Mar; 127(12):1317-29. PubMed ID: 23446829 [TBL] [Abstract][Full Text] [Related]
11. Scavenging of Labile Heme by Hemopexin Is a Key Checkpoint in Cancer Growth and Metastases. Canesin G; Di Ruscio A; Li M; Ummarino S; Hedblom A; Choudhury R; Krzyzanowska A; Csizmadia E; Palominos M; Stiehm A; Ebralidze A; Chen SY; Bassal MA; Zhao P; Tolosano E; Hurley L; Bjartell A; Tenen DG; Wegiel B Cell Rep; 2020 Sep; 32(12):108181. PubMed ID: 32966797 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function. Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878 [TBL] [Abstract][Full Text] [Related]
13. Characterization of Renal Injury and Inflammation in an Experimental Model of Intravascular Hemolysis. Merle NS; Grunenwald A; Figueres ML; Chauvet S; Daugan M; Knockaert S; Robe-Rybkine T; Noe R; May O; Frimat M; Brinkman N; Gentinetta T; Miescher S; Houillier P; Legros V; Gonnet F; Blanc-Brude OP; Rabant M; Daniel R; Dimitrov JD; Roumenina LT Front Immunol; 2018; 9():179. PubMed ID: 29545789 [TBL] [Abstract][Full Text] [Related]
14. Hemopexin as an Inhibitor of Hemolysis-Induced Complement Activation. Poillerat V; Gentinetta T; Leon J; Wassmer A; Edler M; Torset C; Luo D; Tuffin G; Roumenina LT Front Immunol; 2020; 11():1684. PubMed ID: 32849588 [TBL] [Abstract][Full Text] [Related]
15. Divergent roles of haptoglobin and hemopexin deficiency for disease progression of Shiga-toxin-induced hemolytic-uremic syndrome in mice. Pirschel W; Mestekemper AN; Wissuwa B; Krieg N; Kröller S; Daniel C; Gunzer F; Tolosano E; Bauer M; Amann K; Heinemann SH; Coldewey SM Kidney Int; 2022 Jun; 101(6):1171-1185. PubMed ID: 35031328 [TBL] [Abstract][Full Text] [Related]
16. The hemoglobin degradation pathway in patients with preeclampsia - Fetal hemoglobin, heme, heme oxygenase-1 and hemopexin - Potential diagnostic biomarkers? Anderson UD; Jälmby M; Faas MM; Hansson SR Pregnancy Hypertens; 2018 Oct; 14():273-278. PubMed ID: 29530745 [TBL] [Abstract][Full Text] [Related]
17. Hemopexin alleviates sterile inflammation in ischemia-reperfusion-induced lung injury. Nakagiri T; Köhler NR; Janciauskiene S; Neubert L; Knöfel AK; Pradhan P; Ruhparwar A; Ius F; Immenschuh S Front Immunol; 2024; 15():1451577. PubMed ID: 39430764 [TBL] [Abstract][Full Text] [Related]
18. Modulation of Heme-Induced Inflammation Using MicroRNA-Loaded Liposomes: Implications for Hemolytic Disorders Such as Malaria and Sickle Cell Disease. Bashi A; Lekpor C; Hood JL; Thompson WE; Stiles JK; Driss A Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069257 [TBL] [Abstract][Full Text] [Related]
19. Role of hemoglobin/heme scavenger protein hemopexin in atherosclerosis and inflammatory diseases. Mehta NU; Reddy ST Curr Opin Lipidol; 2015 Oct; 26(5):384-7. PubMed ID: 26339767 [TBL] [Abstract][Full Text] [Related]
20. Acute-phase protein hemopexin is a negative regulator of Th17 response and experimental autoimmune encephalomyelitis development. Rolla S; Ingoglia G; Bardina V; Silengo L; Altruda F; Novelli F; Tolosano E J Immunol; 2013 Dec; 191(11):5451-9. PubMed ID: 24154625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]